CytoVive, LLC products

CytoVive specializes in providing advanced FDA-approved Class 2 medical devices under the brands Tropocells and Cellenis, designed for the efficient preparation of autologous Platelet-Rich Plasma (PRP) at the point of care. These PRP kits, intended for single use, leverage proprietary thixotropic gel separator technology. This innovative technology facilitates the extraction of intact platelets, while filtering out proinflammatory cytokines, ensuring high-quality PRP preparations. Key features include a closed system design and a simple three-step protocol that completes in a single five-minute centrifugation spin cycle. The kits allow clinicians to adjust PRP concentrations according to specific clinical needs, supporting a range of regenerative applications. With leukocyte-neutral, natural and exogenously activated PRP options, these kits cater to diverse clinical indications and procedures. Clinicians can confidently use these devices to support effective healing processes, owing to their robust scientific backing and flexible application potentials.

The MiniTC is a portable, FDA-cleared medical device designed by JoinTechLabs to isolate fragmented and purified fat grafts, known as microfat, directly at the point-of-care. It operates as a patented, disposable, closed-loop system that simplifies the processing of lipoaspirate in clinical settings without requiring changes in infrastructure. The device is proficient in yielding highly washed injectable microfat suitable for autologous implants, either standalone or with biocompatible carriers. It supports applications in diverse therapeutic fields, including medical aesthetics, reconstructive surgeries, orthopedics, and wound care. The MiniTC employs a streamlined protocol requiring only two centrifugation stages to produce injectable microfat within approximately 20 minutes, maintaining high cell viability and count. With competitive advantages in cost, efficacy, and a capacity to process 20-100ml of decanted fat, it serves as a robust platform for combination therapies and clinical research.